Leash Bio
Becca Levin, PhD, is currently the Head of Business Development & Corporate Strategy at Leash Bio. She previously held positions at Eikon Therapeutics, Recursion, The Boston Consulting Group, and Apple Tree Partners, focusing on biotech, translational medicine, and venture capital. Becca's educational background includes a PhD in Chemical Biology and Proteomics from the University of California, San Francisco, and a Bachelor's degree in Chemistry from Princeton University. She has also conducted research at Princeton University, The Scripps Research Institute, and Ionis Pharmaceuticals, Inc.
This person is not in any teams
Leash Bio
Every single machine learning (ML)-driven breakthrough, from language translation to Go championships, was immediately preceded not by an algorithmic innovation but by a massive, well-controlled, purpose-built dataset. An ML-driven breakthrough in medicinal chemistry is going to require a similar dataset, but such high-quality, well-structured experimental data doesn’t exist yet. We're building that data set by making physical measurements of lots of targets (with automated in-house protein production) screened against lots of compounds (with DNA-encoded chemical libraries). We're also building the ML models, that will eventually be generalizable across any protein and novel medicines using insights from our models.